Now Is The Time To Build A Position In Tharimmune Inc (NASDAQ:THAR)

In the latest trading session,, 1.53 million Tharimmune Inc (NASDAQ:THAR) shares changed hands as the company’s beta touched 1.19. With the company’s most recent per share price at $1.20 changing hands around $0.0 or 0.01% at last look, the market valuation stands at $2.53M. THAR’s current price is a discount, trading about -437.5% off its 52-week high of $6.45. The share price had its 52-week low at $0.95, which suggests the last value was 20.83% up since then. When we look at Tharimmune Inc’s average trading volume, we note the 10-day average is 10830.0 shares, with the 3-month average coming to 78.50K.

Analysts gave the Tharimmune Inc (THAR) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended THAR as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight. Tharimmune Inc’s EPS for the current quarter is expected to be 0.

Tharimmune Inc (NASDAQ:THAR) trade information

Instantly THAR is in green as seen in intraday trades today. With action 4.35%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -40.89%, with the 5-day performance at 4.35% in the green. However, in the 30-day time frame, Tharimmune Inc (NASDAQ:THAR) is -11.76% down. Looking at the short shares, we see there were 73528.0 shares sold at short interest cover period of 0.48 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 29.89%. The 2025 estimates are for Tharimmune Inc earnings to increase by 5.23%.

THAR Dividends

Tharimmune Inc is expected to release its next quarterly earnings report on 2024-Feb-22.

Tharimmune Inc (NASDAQ:THAR)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 1.48% of Tharimmune Inc shares while 7.07% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.18%.

Among Mutual Funds, the top two as of Jan 31, 2025 were Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund . With 5.52 shares estimated at $6460.0 under it, the former controlled 0.26% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund held about 0.06% of the shares, roughly 1.35 shares worth around $1579.0.